Skip Navigation

JNCI Journal of the National Cancer Institute 1994 86(14):1070-1075; doi:10.1093/jnci/86.14.1070
© 1994 by Oxford University Press
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by van Gurp, R. J. H. L. M.
Right arrow Articles by Looijenga, L. H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Gurp, R. J. H. L. M.
Right arrow Articles by Looijenga, L. H. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 86, No. 14, 1070-1075, July 20, 1994
© 1994 Oxford University Press

Biallelic Expression of the H19 and IGF2 Genes in Human Testicular Germ Cell Tumors

Ruud J. H. L. M. van Gurp, J. Wolter Oosterhuis, Vera Kalscheuer, Edwin C. M. Mariman, Leenderi H. J. Looijenga*

Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center Rotterdam, The Netherlands
Department of Human Genetics, University Hospital Nijmegen Nijmegen, The Netherlands

*Correspondence to: R. J. H. L. M. van Gurp, Laboratory of Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

BACKGROUND:: Genomic imprinting, resulting in the nonequivalence of expression of homologue genes depending on their parental origin, is an important determinant of the developmental potential of embryonic cells. The expression of two genes, one termed H19 and the other IGF2, has been found to be necessary for proper embryonal development in humans. Both the murine and human H19 and IGF2 genes are normally characterized by monoallelic expression.

PURPOSE:: Because testicular germ cell tumors of adults originate from an early germ cell and, to a certain extent, mimic normal embryonal development, we investigated the patterns of allelic expression of the H19 and IGF2 genes in these tumors to determine if genomic imprinting, or a disturbance of it, is involved in their pathogenesis.

METHODS:: Specimens of normal tissue and tumor tissue were obtained from 20 patients with testicular germ cell tumors; 10 of the patients had seminomas and 10 had nonseminomatous germ cell tumors. To determine if there was heterozygosity of the Alu I and Apa I restriction site polymorphism in the H19 and IGF2 genes, respectively, DNA was isolated from cells of the peripheral blood of these patients, then subjected to polymerase chain reaction (PCR) amplification, restriction enzyme digestion, and eiectrophoresis in agarose gels. If heterozygositywas determined, a similar analysis was performed on complementary DNA (cDNA) obtained from matched tumor RNA by reverse transcription and subsequent PCR amplification (RT-PCR). If monoallelic expression was found, matched tumor DNA was studied for possible deletions.

RESULTS:: Tumor samples from 14 of 20 and 11 of 20 patients were informative for allelic expression patterns of the H19 and IGF2 genes, respectively. Analysis of the products of RT-PCR showed biallelic expression of the H19 gene in 12 testicular germ cell tumors (patients numbered 6, 8-13,15, 16, and 18-20) and of the IGF2 gene in 10 testicular germ cell tumors (patients numbered 1, 3, 6, 8-13, and 15-20). The three remaining tumors (patients numbered 2, 4, and 5) had lost the nonexpressed allele.

CONCLUSIONS:: In contrast to normally developing embryos, testicular germ cell tumors show a consistent expression of both parental alleles of the H19 and IGF2 genes.

IMPLICATIONS:: Testicular germ cell tumors of adults may develop from precursor cells in which the imprinting has been either erased or subjected to a consistent relaxation of its effect. [J Natl Cancer Inst 86:1070-1075,1994]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. D. Heaney, M. V. Michelson, K. K. Youngren, M.-Y. J. Lam, and J. H. Nadeau
Deletion of eIF2beta suppresses testicular cancer incidence and causes recessive lethality in agouti-yellow mice
Hum. Mol. Genet., April 15, 2009; 18(8): 1395 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Clin. Chem., December 1, 2008; 54(12): e11 - e79.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. Fottner, S. Sattarova, K. Hoffmann, G. Spottl, and M. M Weber
Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers {alpha}-fetoprotein and human chorionic gonadotropin
Eur. J. Endocrinol., September 1, 2008; 159(3): 317 - 327.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Houldsworth, J. E. Korkola, G. J. Bosl, and R. S. K. Chaganti
Biology and Genetics of Adult Male Germ Cell Tumors
J. Clin. Oncol., December 10, 2006; 24(35): 5512 - 5518.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Cools, S. L. S. Drop, K. P. Wolffenbuttel, J. W. Oosterhuis, and L. H. J. Looijenga
Germ Cell Tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers
Endocr. Rev., August 1, 2006; 27(5): 468 - 484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. H.J. Looijenga, R. Hersmus, A. J.M. Gillis, R. Pfundt, H. J. Stoop, R. J.H.L.M. van Gurp, J. Veltman, H. B. Beverloo, E. van Drunen, A. Geurts van Kessel, et al.
Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte as Tumorigenic Precursor and DMRT1 as Candidate Chromosome 9 Gene
Cancer Res., January 1, 2006; 66(1): 290 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
Y Fellig, I Ariel, P Ohana, P Schachter, I Sinelnikov, T Birman, S Ayesh, T Schneider, N de Groot, A Czerniak, et al.
H19 expression in hepatic metastases from a range of human carcinomas
J. Clin. Pathol., October 1, 2005; 58(10): 1064 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C.E. Hoei-Hansen, J.E. Nielsen, K. Almstrup, M.A. Hansen, N.E. Skakkebaek, E. Rajpert-DeMeyts, and H. Leffers
Identification of genes differentially expressed in testes containing carcinoma in situ
Mol. Hum. Reprod., June 1, 2004; 10(6): 423 - 431.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Modak, S. Gardner, I. J. Dunkel, C. Balmaceda, M. K. Rosenblum, D. C. Miller, S. Halpern, and J. L. Finlay
Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors
J. Clin. Oncol., May 15, 2004; 22(10): 1934 - 1943.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. H. J. Looijenga, H. Stoop, H. P. J. C. de Leeuw, C. A. de Gouveia Brazao, A. J. M. Gillis, K. E. P. van Roozendaal, E. J. J. van Zoelen, R. F. A. Weber, K. P. Wolffenbuttel, H. van Dekken, et al.
POU5F1 (OCT3/4) Identifies Cells with Pluripotent Potential in Human Germ Cell Tumors
Cancer Res., May 1, 2003; 63(9): 2244 - 2250.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. A. Ulaner, T. H. Vu, T. Li, J.-F. Hu, X.-M. Yao, Y. Yang, R. Gorlick, P. Meyers, J. Healey, M. Ladanyi, et al.
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site
Hum. Mol. Genet., March 1, 2003; 12(5): 535 - 549.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. K. Youngren, J. H. Nadeau, and A. Matin
Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications
Hum. Mol. Genet., February 15, 2003; 12(4): 389 - 398.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ishizaki, M. Yoshie, Y. Yaginuma, T. Tanaka, and K. Ogawa
Loss of Igf2 Imprinting in Monoclonal Mouse Hepatic Tumor Cells Is Not Associated with Abnormal Methylation Patterns for the H19, Igf2, and Kvlqt1 Differentially Methylated Regions
J. Biol. Chem., February 14, 2003; 278(8): 6222 - 6228.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A.-M. F. Kersemaekers, F. Mayer, M. Molier, P. C. van Weeren, J. W. Oosterhuis, C. Bokemeyer, and L. H.J. Looijenga
Role of P53 and MDM2 in Treatment Response of Human Germ Cell Tumors
J. Clin. Oncol., March 15, 2002; 20(6): 1551 - 1561.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. D. Ravenel, K. W. Broman, E. J. Perlman, E. L. Niemitz, T. M. Jayawardena, D. W. Bell, D. A. Haber, H. Uejima, and A. P. Feinberg
Loss of Imprinting of Insulin-Like Growth Factor-II (IGF2) Gene in Distinguishing Specific Biologic Subtypes of Wilms Tumor
J Natl Cancer Inst, November 21, 2001; 93(22): 1698 - 1703.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. T. Schneider, A. E. Schuster, M. K. Fritsch, J. Hu, T. Olson, S. Lauer, U. Gobel, and E. J. Perlman
Multipoint Imprinting Analysis Indicates a Common Precursor Cell for Gonadal and Nongonadal Pediatric Germ Cell Tumors
Cancer Res., October 1, 2001; 61(19): 7268 - 7276.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. K. Chaganti and J. Houldsworth
Genetics and Biology of Adult Human Male Germ Cell Tumors
Cancer Res., March 1, 2000; 60(6): 1475 - 1482.
[Abstract] [Full Text]


Home page
J. Med. Genet.Home page
D. CATCHPOOLE, A. V SMALLWOOD, J. A JOYCE, A. MURRELL, W. LAM, T. TANG, D. MUNROE, W. REIK, P. N SCHOFIELD, and E. R MAHER
Mutation analysis of H19 and NAP1L4 (hNAP2) candidate genes and IGF2 DMR2 in Beckwith-Wiedemann syndrome
J. Med. Genet., March 1, 2000; 37(3): 212 - 215.
[Full Text]


Home page
Am. J. Pathol.Home page
J. G. Falls, D. J. Pulford, A. A. Wylie, and R. L. Jirtle
Genomic Imprinting: Implications for Human Disease
Am. J. Pathol., March 1, 1999; 154(3): 635 - 647.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Lepretre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, and J.-J. Curgy
H19 Overexpression in Breast Adenocarcinoma Stromal Cells Is Associated with Tumor Values and Steroid Receptor Status but Independent of p53 and Ki-67 Expression
Am. J. Pathol., November 1, 1998; 153(5): 1597 - 1607.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Gicquel, M.-L. Raffin-Sanson, V. Gaston, X. Bertagna, P.-F. Plouin, M. Schlumberger, A. Louvel, J.-P. Luton, and Y. Le Bouc
Structural and Functional Abnormalities at 11p15 Are Associated with the Malignant Phenotype in Sporadic Adrenocortical Tumors: Study on a Series of 82 Tumors
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2559 - 2565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-H. Wang, J.-X. Duan, T. H. Vu, and A. R. Hoffman
Increased Expression of the Insulin-like Growth Factor-II Gene in Wilms' Tumor Is Not Dependent on Loss of Genomic Imprinting or Loss of Heterozygosity
J. Biol. Chem., November 1, 1996; 271(44): 27863 - 27870.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Q. Liu, H. Yan, N. J. Dawes, G. A. Mottino, J. S. Frank, and H. Zhu
Insulin-like Growth Factor II Induces DNA Synthesis in Fetal Ventricular Myocytes In Vitro
Circ. Res., October 1, 1996; 79(4): 716 - 726.
[Abstract] [Full Text]


Home page
DevelopmentHome page
G. Adam, H Cui, S. Miller, F Flam, and R Ohlsson
Allele-specific in situ hybridization (ASISH) analysis: a novel technique which resolves differential allelic usage of H19 within the same cell lineage during human placental development
Development, January 3, 1996; 122(3): 839 - 847.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.